FUNDING FLAGSHIP 3 ( 2016 - 2020 )
Sydney Vital : $ 671 , 454
External Sources : $ 1 , 580 , 454
Item 1 29.8%
Item 2 34.7%
33.2%
Item 1 65.3%
66.8%
Item 2 70.2%
External Sources include : CINSW , Cancer Council NSW , NHMRC , Ramsay Foundation , and CSSANZ
RESEARCH SUCCESSES
Obtained two patents : X - ray triggered chemotherapy and PCT based on our liposome - CRISPR delivery technology . Developed a program about X - ray - triggered photodynamic therapy ( X - PDT ) demonstrating for the first time improved rectal cancer survival in mice with X - PDT delivered via engineered nanocarriers made from a clinically approved polymer . Developed a theranostic magnetic nano - platform for non - invasively detecting , diagnosing and eliminating lymph node metastases . Developed a model for colorectal polyp development , understand risk of lymphnode metastasis in very early ( malignant polyp ) colorectal cancer and enhance polyp recognition using nano - optonics ( close collaboration with Colorectal TCE and Prof Mark Molloy ). Demonstrated the efficacy of X - ray triggered chemotherapy in colorectal cancer .
P A G E
1 8
Made with FlippingBook - professional solution for displaying marketing and sales documents online